AzTrials
AzTrials

Hernia, InguinalPhase 4NCT00827944

Parietex Progrip Study

A Phase 4 study testing Parietex Progrip and Low weight polypropylene mesh in people with Hernia, Inguinal, run by Medtronic - MITG at 9 sites in 5 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of the study is to evaluate pain and disabling complications inducing social consequences in primary inguinal hernia ProGrip mesh repair compared to Lichtenstein repair with lightweight polypropylene mesh. Read more about this study

Who is it for?
Ages 31 to 74 years, men only
Conditions the study is for
Hernia, Inguinal
What is being tested?
Parietex Progrip and Low weight polypropylene mesh
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
603 participants
Where
9 sitesin 5 countries
Study dates
Oct 2008to Oct 2012
Phase
Phase 4
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 31 to 74 years
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All male patients at participating centers with a primary, uncomplicated inguinal hernia.
  • Collar of the defect ≤ 4 cm
  • Signed informed consent
  • Bilateral inguinal hernia
  • Recurrence

Who cannot join

  • 30 years ≥ Age ≥ 75 years
  • Emergency procedure

Trial locations and contacts

9 sites in 5 countries.

9 sites in 5 countries

United Kingdom3 sites
  • Western Infirmary

    Glasgow, G11 6NT

  • Imperial College London / Faculty of Medecine

    London, W2 1NY

  • Derriford Hospital

    Plymouth, PL6

Other trials in United Kingdom

Germany2 sites
  • Klinikum Bremen-Mitte

    Bremen, 28177

  • Herz-Jesu-Krankenhaus gGmbH, Chirurgische Klinik

    Fulda, D- 36039 Fulda

Other trials in Germany

Sweden2 sites
  • Medical Center Linköping

    Linköping, 582 24

  • Centre of clinical research

    Västeras-, 721 89

Other trials in Sweden

Belgium1 site
  • Universitaire Ziekenhuizen Leuven

    Leuven, 3000

Other trials in Belgium

Netherlands1 site
  • Catharina-ziekenhuis

    Eindhoven, 5623 EJ

Other trials in Netherlands

About this study

Official title: ProGrip Mesh Repair Versus Lichtenstein Mesh Repair: a Comparative Randomized Study in Primary Inguinal Hernia

The objective of the study is to evaluate pain and disabling complications inducing social consequences in primary inguinal hernia ProGrip mesh repair compared to Lichtenstein repair with lightweight polypropylene mesh.

Read the detailed description
  • Patients in ProGrip group will be treated with self-gripping lightweight Polyester and Polylactic acid meshes providing a sutureless fixation.
  • Patients in Lichtenstein group will be treated with lightweight Polypropylene meshes requiring fixation by sutures.
  • Study participation will start at signature of informed consent and each patient will be assessed before surgery. A close follow-up will be performed: 7 days (questionnaires and phone call), 1 month (clinical visit), 3 months (questionnaires and phone call), and final evaluation at 12 months (clinical visit) after surgery, which will end the participation to the study.
  • 600 adult males divided in 2 groups requiring primary uncomplicated elective inguinal hernia mesh repair will be included in the study. Patients will be stratified by center.
Being tested
Parietex Progrip, Low weight polypropylene mesh
Keywords
Uncomplicated primary inguinal hernias
Medical subject headings
Hernia, Inguinal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Parietex ProgripDevice

    Surgical technique:

    Self-gripping lightweight Polyester and Polylactic acid meshes providing a sutureless fixation.

  • Low weight polypropylene meshDevice

    Surgical technique:

    Lichtenstein repair with lightweight polypropylene mesh (inferior to 70gr/m2) secured to the posterior inguinal wall with sutures

Study groups in NCT00827944
Study groupRoleWhat they receive
1Active comparatorParietex ProGrip
Receives: Device: Parietex Progrip
2Active comparatorLow weight polypropylene mesh
Receives: Device: Low weight polypropylene mesh

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain Assessment During the First Three Months and at One Year After Surgery Using a Visual Analogue Scale (VAS)

    Pain assessment during patient follow up after surgery using VAS score. VAS going from 0 mm (no pain) to 150 mm (worst conceivable pain) is presented to the patient who draw a vertical line on the scale to indicate the average amount of pain at the time of consultation or at home.

    Measured: M3, M12 after surgery

  2. Pain Assessment During the First Three Months and at One Year After Surgery Using a Surgical Pain Scales (SPS)

    Surgical pain scales (=SPS) completed by patient during consultation or will be sent to the patient with instructions to complete it and send it back by mailing. The score of evaluation will be reported in mm, specifying if pain occurs at rest, during normal activities, during exercise. The score is ranged from 0 (no pain) to 150 mm (the worst pain yu have never known).

    Measured: M3, M12 after surgery

Secondary outcomes (5)
  1. Foreign Body Sensation

    Foreign body sensation using a specific questionnaire at M1, M3, M12 months after surgery. Questionnaire will be completed by patient during consultation or will be sent to the patient with instructions to complete it and send it back by mailing.

    Measured: M1, M3, M12 months after surgery

  2. Chronic Pain Defined as Pain Lasting More Than 3 Months Using VAS Score

    Chronic pain defined as pain lasting more than 3 months using VAS score. A VAS going from 0 mm (no pain) to 150 mm (worst conceivable pain) is presented to the patient who draw a vertical line on the scale to indicate the average amount of pain at the time of consultation or at home.

    Measured: 3 months after surgery

  3. Wound Complications and Hernia Recurrences

    Measured: M12 after surgery

  4. Return to Work and to Normal Daily Activities

    Measured: Effective date

  5. Other Post-operative Complications

    Measured: M12 after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jan 2009 (estimated)
  2. Study startOct 2008
  3. Primary completionOct 2012
  4. Study completionOct 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
603 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00827944
Sponsor's protocol ID
SC 0607/1
Status last verified
Nov 2016
First submitted
22 Jan 2009
Last updated
17 Nov 2016
Data monitoring committee
No

Publications

  • Sanders DL, Nienhuijs S, Ziprin P, Miserez M, Gingell-Littlejohn M, Smeds S. Randomized clinical trial comparing self-gripping mesh with suture fixation of lightweight polypropylene mesh in open inguinal hernia repair. Br J Surg. 2014 Oct;101(11):1373-82; discussion 1382. doi: 10.1002/bjs.9598. Epub 2014 Aug 21.

    PubMed 25146918

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Parietex Progrip and Low weight polypropylene mesh in people with Hernia, Inguinal, run by Medtronic - MITG at 9 sites in 5 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Nov 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 9 sites in United Kingdom, Germany, Sweden, Belgium, Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 17 Nov 2016). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain Assessment During the First Three Months and at One Year After Surgery Using a Visual Analogue Scale (VAS) (time frame: M3, M12 after surgery). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00827944, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Nov 2016; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in